Eric Feigl-Ding

Eric Feigl-Ding
Born	(1983-03-28) March 28, 1983 Shanghai, China
🏳️ Nationality	United States
Other names	Eric Ding
🏫 Education	PhD (Harvard), BA (Johns Hopkins)
🎓 Alma mater	Harvard University Johns Hopkins University
💼 Occupation	Public Health Scientist (epidemiologist, nutritionist, health economist)
🏡 Home town	Shippensburg, PA, USA
🏅 Awards	Boston Chamber of Commerce TOYL Award (2012) AHA Scott Grundy Excellence Award (2015) CUGH Global Health Project of the Year Prize (2014) Sigma Chi Anderson Leadership Award (2016) Soros Fellow (2008) Harvard Derek Bok Distinction in Teaching Award (2009)
🌐 Website	scholar.harvard.edu/ericding

Eric L. Feigl-Ding is an American public health scientist who has received awards for his work in epidemiology, nutrition, and health economics. He is a faculty member at the Harvard School of Public Health and Chief Health Economist and Senior Vice President with Microclinic International. He is a Paul and Daisy Soros Fellow, and a WEF Global Shaper. He was also a 2018 Democratic candidate for Congress from Pennsylvania's 10th congressional district, as an advocate for public health, drug safety, and science.

Ding was a whistle-blower in the drug safety risks of the painkillers Vioxx, Celebrex, and Bextra, and was recognized in The New York Times, and in the book Poison Pills: The Untold Story of the Vioxx Drug Scandal.

Ding founded the Campaign for Cancer Prevention, a 6 million member online cancer education and fundraising campaign medical research, featured in The New York Times He is a recognized drinking water health advocate and founded ToxinAlert.org, as a public alert tool to warn communities about drinking water contaminations to prevent future lead poisonings like the Flint Water Crisis.

Early life and education

Feigl-Ding was born in Shanghai, China, and his family immigrated to the US when he was age 5. He was raised in Central Pennsylvania, and was an alum of the Pennsylvania Governor's School for Health Care. As a child, doctors diagnosed that he had developed a baseball-size tumor in his chest. He received an initial disease prognosis of less than 5 years to live, but he survived with medical treatment he received at Hershey Medical Center.

He attended The Johns Hopkins University, graduating with Honors in Public Health and Phi Beta Kappa. He earned his dual doctorate in epidemiology, and his doctorate in nutrition, with a doctoral minor in biostatistics, from Harvard at age 23. He then completed his postdoctoral fellowship at the Harvard School of Public Health. At Harvard, he has taught in more than 2 dozen courses in public health and clinical research, and received the Derek Bok Distinction in Teaching Award from Harvard College. He attended Boston University School of Medicine, but did not complete the M.D. degree because of competing commitments.

Work

Feigl-Ding's work focuses on epidemiology, nutrition, health economics, and the prevention of population-wide disease. He has published over 100+ scientific papers, including major reports in the New England Journal of Medicine, Journal of the American Medical Association, PLoS Medicine, The Lancet. His body of research together have garnered over 36,000 external citations.

He was a whistle-blower in the drug controversy surrounding the safety and risks of the dangerous painkillers Vioxx, Celebrex, and Bextra. Chief corresponding author of a priority JAMA report, he was recognized for his role in The New York Times,. Dr. Ding's key study established that Merck should have known the serious health dangers of Vioxx several years before the drug was pulled off the market, as chronicled in the book Poison Pills: The Untold Story of the Vioxx Drug Scandal.

He was also Chief Health Economist and Director of Epidemiology of Microclinic International, as co-principal investigator of several intervention programs for obesity and diabetes prevention in the US and abroad. He has also led the Team Up 4 Health program with Kentucky's Bell County Health Department to improve rural obesity. He also developed and led adolescent nutrition public health programs with Statens Serum Institut of the Danish Ministry of Health. He also co-developed the community health program for obesity/diabetes used by the UN and currently serving hundreds of thousands of UNRWA Palestinian refugees in Jordan and Palestine since 2015, which have successfully reduced diabetes and obesity throughout refugee centers in the Middle East.

Having survived a childhood battle with a baseball-sized tumor, Feigl-Ding founded the Campaign for Cancer Prevention, and was featured in Newsweek, The New York Times,. He is also known for developing a direct-to-science model for accelerating cancer research, and advocate of crowdfunding for medical research. His efforts had raised over $500,000 in public donations for innovative cancer research, and he led cancer prevention advocacy platforms totaling over 6 million members.

He was also a consultant to the World Health Organization, advisor and report chairman for the European Commission, as judge for the VH1 Do Something Awards, and an expert member of the Global Burden of Disease Project and US Burden of Disease Collaboration. His work has been cited by directors of CDC and CMMS in the framework of the "Million Hearts" Initiative, his research thrice recognized as ‘Best of American Heart Association’. A former keynote presenter at Google TechTalk, Feigl-Ding has been featured in Google Research for development of a 130-year cohort study of Major League Baseball of the dangers of obesity and mortality in athletes.

Political Campaign

Feigl-Ding ran for Congress as Democratic candidate representing his native Pennsylvania's 10th congressional district. He campaigned on a progressive platform advocating science, healthcare for all, public health, and not taking corporate PAC money. During the new PA 10th district primary, his grassroots campaign outraised every opponent with $300,000 in just 10 weeks, including the Republican incumbent Scott Perry. He received the most national endorsements in the primary, and garnered the support of individuals and groups including: Rep. Jerry McNerney (D-CA), DNC Vice-Chair and Rep. Grace Meng (D-NY), Rep. Brian Baird (D-WA), 314 Action, Congressional Asian Pacific American Caucus's ASPIRE, AAPI Victory Fund, Harrisburg City Council President Wanda Williams, Science Energy & Environment Change, At The Table, United Brotherhood of Carpenters, International Union of Painters and Allied Trades, and the International Union of Operating Engineers. His campaign was also featured in Science Magazine.

Recognitions and Awards

His work has been featured in several books, including CauseWired: Plugging In, Getting Involved, Changing the World,, Poison Pills: The Untold Story of the Vioxx Drug Scandal, Zilch: The Power of Zero in Business, Shift & Reset: Strategies for Addressing Serious Issues in a Connected Society, The Networked Non-profit, and Thinfluence.

He has received awards, including the Boston Chamber of Commerce's Outstanding Young Leader Award (2012), the American Heart Association's Scott Grundy Excellence Award (2015), the 'Best of the American Heart Association' (2013, 2014, 2015), the Sigma Chi Mark V. Anderson Leadership Award (2016), the CUGH's Global Health Project of the Year Prize (2014), the Paul and Daisy Soros Fellowship for New Americans (2008), and the Harvard University Derek Bok Distinction in Teaching Award (2009). He was also recognized by Craig Newmark as among “16 People and Organizations Changing the World in 2012”.

External links

• Website at Harvard School of Public Health

This article "Eric Ding" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Eric Ding. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.

📰 Article(s) of the same category(ies)

• Karen Liu
• Kaitlin Samocha
• Sema Sgaier
• Nayef Al-Rodhan
• Amanda Glassman
• Wolfgang Klietmann
• Sunshine Shen

---